Di Noia, Vincenzo Pio
 Distribuzione geografica
Continente #
NA - Nord America 317
EU - Europa 223
AS - Asia 117
SA - Sud America 27
AF - Africa 9
Totale 693
Nazione #
US - Stati Uniti d'America 313
SE - Svezia 64
IT - Italia 51
SG - Singapore 45
CN - Cina 33
BR - Brasile 27
DE - Germania 22
FR - Francia 21
IN - India 19
IE - Irlanda 16
BE - Belgio 9
CI - Costa d'Avorio 9
ID - Indonesia 9
GB - Regno Unito 6
CZ - Repubblica Ceca 5
FI - Finlandia 5
AT - Austria 4
RU - Federazione Russa 4
CA - Canada 3
PL - Polonia 3
RO - Romania 3
UA - Ucraina 3
HK - Hong Kong 2
IR - Iran 2
KG - Kirghizistan 2
LT - Lituania 2
NL - Olanda 2
BY - Bielorussia 1
ES - Italia 1
IL - Israele 1
IQ - Iraq 1
KR - Corea 1
MD - Moldavia 1
MX - Messico 1
TR - Turchia 1
VN - Vietnam 1
Totale 693
Città #
Chandler 83
Singapore 30
Cattolica 26
Ashburn 23
Ann Arbor 22
Dublin 16
Redmond 15
Hyderabad 10
Abidjan 9
Brussels 9
Jakarta 9
Marseille 9
San Mateo 9
Boardman 7
Boston 7
Princeton 7
The Dalles 7
Dearborn 6
Düsseldorf 6
Brno 5
Bremen 4
Jacksonville 4
Rome 4
Wilmington 4
Detroit 3
Helsinki 3
Los Angeles 3
Milan 3
Moscow 3
Nanchang 3
Nanjing 3
Norwalk 3
Portsmouth 3
Tianjin 3
Toronto 3
Vienna 3
Warsaw 3
Andover 2
Bishkek 2
Council Bluffs 2
Fairfield 2
Guangzhou 2
Hong Kong 2
Ladispoli 2
Lauterbourg 2
Lawrence 2
London 2
New Haven 2
Ribeirão Preto 2
Bacuri 1
Beijing 1
Bom Conselho 1
Brasília 1
Brooklyn 1
Campinas 1
Capão do Leão 1
Caratinga 1
Cervignano del Friuli 1
Changsha 1
Chicago 1
Chisinau 1
Civitanova Marche 1
Cosmorama 1
Dallas 1
Delhi 1
Duque de Caxias 1
Erbil 1
Frankfurt am Main 1
Fremont 1
Groningen 1
Gurgaon 1
Hefei 1
Ho Chi Minh City 1
Houston 1
Itabira 1
Itaguaí 1
Itapema 1
Jaguaruna 1
Jequié 1
Jiaxing 1
Kashan 1
Kish 1
Lancaster 1
León 1
Magnesia ad Sipylum 1
Munich 1
Nuoro 1
Osasco 1
Palermo 1
Phoenix 1
Pilar do Sul 1
Quanzhou 1
Redwood City 1
Reghin 1
Salto 1
Santa Clara 1
Santa Luzia 1
Santos 1
Seattle 1
Seoul 1
Totale 445
Nome #
Are TKIs favourable for the elderly with non-small-cell lung cancer? 114
Is surgery mandatory in locally advanced gastrointestinal stromal tumors after imatinib? A case report and literature review. 95
Blood serum amyloid A as potential biomarker of pembrolizumab efficacy for patients affected by advanced non-small cell lung cancer overexpressing PD-L1: results of the exploratory “FoRECATT” study 93
Transradial versus Transfemoral Access for Hepatic Chemoembolization: Intrapatient Prospective Single-Center Study 76
PTEN Loss as a Predictor of Tumor Heterogeneity and Poor Prognosis in Patients With EGFR-mutant Advanced Non–small-cell Lung Cancer Receiving Tyrosine Kinase Inhibitors 75
Exploring the molecular and biological background of lung neuroendocrine tumours 65
Oncogene-addicted non-small-cell lung cancer: Treatment opportunities and future perspectives 64
Molecular Testing in EBUS-TBNA Specimens of Lung Adenocarcinoma: A Study of Concordance Between Cell Block Method and Liquid-Based Cytology in Appraising Sample Cellularity and EGFR Mutations 63
Multisite artery disease: a common and challenging clinical condition calling for specific management 52
Baseline BMI and BMI variation during first line pembrolizumab in NSCLC patients with a PD-L1 expression ≥ 50%: A multicenter study with external validation 12
Totale 709
Categoria #
all - tutte 3.590
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.590


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202018 0 0 0 0 0 0 0 0 0 0 10 8
2020/202137 6 2 0 0 5 2 2 2 3 1 10 4
2021/2022102 25 1 1 9 7 2 0 12 4 1 13 27
2022/2023215 24 27 22 42 9 32 18 13 21 1 2 4
2023/202475 0 31 2 2 0 4 4 5 2 2 9 14
2024/2025176 10 5 17 12 12 4 8 7 27 34 40 0
Totale 709